相关实验视频

Updated: Jul 8, 2025

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
08:20

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

1.9K

无活化疫苗降低了COVID-19的NAFLD患者肝功能异常的风险:一个多中心回顾性研究

Zhixue Chen1, Wenqing Tang1, Nana Feng2

  • 1Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Diseases, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

EBioMedicine
|December 14, 2023
PubMed
概括

接种COVID-19疫苗可能会保护非酒精性脂肪性肝病 (NAFLD) 患者免受肝功能障碍. 该研究发现,SARS-CoV-2疫苗在COVID-19的NAFLD患者中减少了肝脏异常和病毒分泌.

关键词:
在 COVID-19 疫情中,直接的 bilirubin 是一种直接的 bilirubin.无活化的SARS-CoV-2疫苗肝功能异常 肝功能异常非酒精性脂肪性肝病是非酒精性脂肪性肝病.

更多相关视频

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

924

相关概念视频

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
559